KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Eli Lilly (LLY) over the last 13 years, with Q1 2022 value amounting to $950.6 million.

  • Eli Lilly's Shares Outstanding fell 92.52% to $950.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $950.6 million, marking a year-over-year decrease of 92.52%. This contributed to the annual value of $954.1 million for FY2021, which is 30.94% down from last year.
  • As of Q1 2022, Eli Lilly's Shares Outstanding stood at $950.6 million, which was down 92.52% from $954.1 million recorded in Q4 2021.
  • Eli Lilly's Shares Outstanding's 5-year high stood at $1.1 billion during Q1 2018, with a 5-year trough of $950.6 million in Q1 2022.
  • Moreover, its 5-year median value for Shares Outstanding was $958.1 million (2019), whereas its average is $985.5 million.
  • In the last 5 years, Eli Lilly's Shares Outstanding tumbled by 1082.15% in 2019 and then grew by 26.68% in 2021.
  • Eli Lilly's Shares Outstanding (Quarter) stood at $1.1 billion in 2018, then fell by 9.42% to $958.1 million in 2019, then fell by 0.1% to $957.1 million in 2020, then dropped by 0.31% to $954.1 million in 2021, then dropped by 0.37% to $950.6 million in 2022.
  • Its Shares Outstanding was $950.6 million in Q1 2022, compared to $954.1 million in Q4 2021 and $957.1 million in Q3 2021.